Welcome to LookChem.com Sign In|Join Free
  • or
4,4,5,5-tetramethyl-2-(4-(phenylsulfonyl)phenyl)-1,3,2-dioxaborolane is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1361215-96-4

Post Buying Request

1361215-96-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1361215-96-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1361215-96-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,1,2,1 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1361215-96:
(9*1)+(8*3)+(7*6)+(6*1)+(5*2)+(4*1)+(3*5)+(2*9)+(1*6)=134
134 % 10 = 4
So 1361215-96-4 is a valid CAS Registry Number.

1361215-96-4Relevant academic research and scientific papers

Spiroconjugated Tetraaminospirenes as Donors in Color-Tunable Charge-Transfer Emitters with Donor-Acceptor Structure

Grenz, David C.,Rose, Daniel,W?ssner, Jan S.,Wilbuer, Jennifer,Adler, Florin,Hermann, Mathias,Chan, Chin-Yiu,Adachi, Chihaya,Esser, Birgit

, (2021/12/22)

Charge-transfer emitters are attractive due to their color tunability and potentially high photoluminescence quantum yields (PLQYs). We herein present tetraaminospirenes as donor moieties, which, in combination with a variety of acceptors, furnished 12 charge-transfer emitters with a range of emission colors and PLQYs of up to 99 %. The spatial separation of their frontier molecular orbitals was obtained through careful structural design, and two DA structures were confirmed by X-ray crystallography. A range of photophysical measurements supported by DFT calculations shed light on the optoelectronic properties of this new family of spiro-NN-donor-acceptor dyes.

Organic compound and electroluminescent device using same

-

Paragraph 0065-0067; 0070-0072, (2021/01/29)

The present invention provides an organic compound and an electroluminescent device using the same. The organic compound has a structure represented by a formula I, and the organic compound provided by the present invention is a D-carbazole-A configuratio

Cyclometalated Platinum Complexes with Aggregation-Induced Phosphorescence Emission Behavior and Highly Efficient Electroluminescent Ability

Zhao, Jiang,Feng, Zhao,Zhong, Daokun,Yang, Xiaolong,Wu, Yong,Zhou, Guijiang,Wu, Zhaoxin

, p. 929 - 946 (2018/02/19)

Aggregation-induced emission (AIE) materials can exhibit intense luminescence in the aggregated or solid state, which are highly desirable for OLED application. However, only limited research results on developing AIE-active PtII complexes in e

Bis-ZnII salphen complexes bearing pyridyl functionalized ligands for efficient organic light-emitting diodes (OLEDs)

Zhao, Jiang,Dang, Feifan,Liu, Boao,Wu, Yong,Yang, Xiaolong,Zhou, Guijiang,Wu, Zhaoxin,Wong, Wai-Yeung

supporting information, p. 6098 - 6110 (2017/07/11)

Inspired by the emissive features of ZnII complexes based on bis-Schiff base ligands, bis-ZnII salphen complexes bearing pyridyl functionalized ligands have been successfully synthesized. Their photophysical features, electrochemical

Bipolar diphenyl sulphone -based blue phosphorescence body material and its preparation method and device

-

Paragraph 0040; 0041, (2016/10/07)

The invention discloses a diphenyl sulfone-based bipolar blue phosphor host material, which is formed by diphenyl sulfone with electronic transmission ability and a carbazole group with hole transmission ability. The structural formula of the diphenyl sul

SULFONYL COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN

-

, (2013/08/28)

The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES

-

, (2012/03/26)

The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1361215-96-4